-
HER2+ Market to Accelerate Substantially by 2034, Predicts DelveInsight | Key Companies - Zymeworks, Jazz Pharmaceuticals, Ambrx, AnBogen Therapeutics, Enliven Therapeutics, Roche
17 Apr 2024 17:00 GMT
… HER2+ clinical trials, visit @ HER2+ Treatment Drugs HER2+ Overview … These targeted treatments, such as Herceptin and Perjeta … testing, helping doctors tailor treatment plans to … Tracon Pharmaceuticals Inc., Celgene, MedImmune, Hangzhou Sumgen Biotech, among …
-
Novartis pauses enrollment in some Kisqali trials to fix manufacturing
10 Apr 2024 16:21 GMT
… certain clinical trials of its breast cancer drug Kisqali in … with hormone drugs but not with a therapy like Herceptin that … the post-surgical, “adjuvant” treatment setting to prevent recurrence of … Lilly’s trial of Verzenio.
Novartis asked the FDA to approve …
-
ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (“R/R B-NHL”)
09 Apr 2024 21:30 GMT
… initial treatment,” said Paolo Strati, M.D., the trial’s … M.D., Ph.D., Chief Medical Officer, ALX Oncology. “Furthermore, … cancer antibodies (e.g., Herceptin®) with an active Fc domain … studies and clinical trials, results of clinical trials, research and …
-
FDA grants accelerated approval to Enhertu for adults with advanced solid tumors
08 Apr 2024 17:29 GMT
… antibody-drug conjugate, is approved in the United States for treatment of … a prior trastuzumab (Herceptin, Genentech)-based regimen.
FDA based the accelerated approval … efficacy data from three multicenter trials.
The FDA previously granted the application …
-
Samsung Biopeis’ Keytruda biosimilar enters Phase III trials
05 Apr 2024 19:24 GMT
… SB27.
The randomised trial will compare SB27 against … the highest-selling drug across all treatment spaces last year, … parent company of Clinical Trials Arena.
Samsung Bioepis is … drugs including Humira, Immunex’s Enbrel (etanercept) and Genentech’s Herceptin …
-
US FDA approves Daiichi, AstraZeneca drug for treatment of solid tumors
05 Apr 2024 21:49 GMT
… fresh approval opens the treatment across multiple HER2-expressing … in three mid-stage trials. AstraZeneca secured partial rights … drug generated sales of $1.28 billion as a treatment for … as Herceptin) - chemically linked to a cell-killing chemotherapy drug. …
-
Opinion: Personalized medicine: We’re not there yet
05 Apr 2024 12:53 GMT
… accessing the tests and treatments underpinning personalized medicine.
20 years of progress … targeted drugs, though these approvals did provide proofs of principle.
Herceptin (trastuzumab … all clinical trials in cancer care are now for drugs that are …
-
Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers
04 Apr 2024 17:05 GMT
… receptor antagonist marketed as Herceptin® by Roche and its … escalation and dose optimization trial has an estimated primary … for indications that include treatment of adults with advanced … teams, and its drug discovery and drug hunting scientists.
“Over …
-
Novel Injection Earns FDA ODD in Breast Cancer Brain Metastases
03 Apr 2024 20:45 GMT
The FDA has granted orphan drug designation to utidelone injectable … results from 2 phase 2 trials: UTOBIA-BM (NCT05781633) … a response from trastuzumab (Herceptin) or pyrotinib.
The primary … another treatment, or participation on another clinical trial within …
-
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
18 Apr 2024 21:48 GMT
… ), a clinical-stage biotechnology company focused on the treatment and prevention of … trials."
Dr. Sanjay Juneja is a board-certified hematologist and medical … Shepard, Ph.D., inventor of Herceptin; and many others. The full …